These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 17216825

  • 21. Role of surgery combined with kinase inhibition in the management of gastrointestinal stromal tumor (GIST).
    Hohenberger P, Eisenberg B.
    Ann Surg Oncol; 2010 Oct; 17(10):2585-600. PubMed ID: 20407930
    [Abstract] [Full Text] [Related]

  • 22. Gastrointestinal stromal tumor of the esophagus.
    Dan D, Seetahal S, Persad R.
    J Natl Med Assoc; 2009 May; 101(5):462-5. PubMed ID: 19476200
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Gastrointestinal stromal tumors: imatinib and beyond.
    Schnadig ID, Blanke CD.
    Curr Treat Options Oncol; 2006 Nov; 7(6):427-37. PubMed ID: 17032555
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Response to imatinib in KIT- and PDGFRA-wild type gastrointestinal stromal associated with neurofibromatosis type 1.
    Lee JL, Kim JY, Ryu MH, Kang HJ, Chang HM, Kim TW, Lee H, Park JH, Kim HC, Kim JS, Kang YK.
    Dig Dis Sci; 2006 Jun; 51(6):1043-6. PubMed ID: 16865565
    [No Abstract] [Full Text] [Related]

  • 30. Long-term follow-up outcome of imatinib mesylate treatment for recurrent and unresectable gastrointestinal stromal tumors.
    Saito S, Nakata K, Kajiura S, Ando T, Hosokawa A, Sugiyama T.
    Digestion; 2013 Jun; 87(1):47-52. PubMed ID: 23343969
    [Abstract] [Full Text] [Related]

  • 31. Imatinib mesylate induces responses in patients with liver metastases from gastrointestinal stromal tumor failing intra-arterial hepatic chemotherapy.
    Fiorentini G, Bernardeschi P, Rossi S, Dentico P, Biancalani M, Giustarini G, Turrisi G.
    J Cancer Res Ther; 2006 Jun; 2(2):68-71. PubMed ID: 17998678
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Gastrointestinal stromal tumor in a child and review of the literature.
    Hayashi Y, Okazaki T, Yamataka A, Yanai T, Yamashiro Y, Tsurumaru M, Kajiyama Y, Miyano T.
    Pediatr Surg Int; 2005 Nov; 21(11):914-7. PubMed ID: 16240136
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Rhabdomyosarcomatous differentiation in gastrointestinal stromal tumors after tyrosine kinase inhibitor therapy: a novel form of tumor progression.
    Liegl B, Hornick JL, Antonescu CR, Corless CL, Fletcher CD.
    Am J Surg Pathol; 2009 Feb; 33(2):218-26. PubMed ID: 18830121
    [Abstract] [Full Text] [Related]

  • 38. Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib.
    Bauer S, Hartmann JT, de Wit M, Lang H, Grabellus F, Antoch G, Niebel W, Erhard J, Ebeling P, Zeth M, Taeger G, Seeber S, Flasshove M, Schütte J.
    Int J Cancer; 2005 Nov 01; 117(2):316-25. PubMed ID: 15900603
    [Abstract] [Full Text] [Related]

  • 39. A Rare Diagnosis After the Fall of a 96-Year-Old Woman: Doege-Potter Syndrome.
    Pincelli AI, Perotti M, Massariello F, Gatti A, Calella D, Cimino V, Haas J, Bellelli G, Mazzola P, Annoni G.
    Curr Aging Sci; 2018 Nov 01; 11(3):195-200. PubMed ID: 30520387
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.